Cardiomyopathy Terminated Phase Trials for Ranolazine (DB00243)

Also known as: Cardiomyopathies / Cardiomyopathy, unspecified / Myocardial degeneration / Myocardial disease (disorder) / Cardiomyopathy NOS / Cardiomyopathy (disorder) / Myocardiodystrophy

IndicationStatusPhase
DBCOND0007414 (Cardiomyopathy)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01705509
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)Supportive Care